Company intelligence / Profile preview

Enzo Biochem, Inc.

Farmingdale, NY, USAenzo.com ↗

Ownership: Public · ENZ
Employees: ~125
Development stage: Other

Overview

The company provides high-quality labeling/detection products critical to biomedical research and drug development. It monetizes technology primarily through global sales and licensing. No clinical trial results available as it does not develop drugs itself.

Therapeutic areas: Oncology
Modalities: Labeling and detection technologies for DNA to whole cell analysisAntibodiesGenomic probesAssaysBiochemicals and proteins
Industry: Molecular Diagnostics

Partnerships

Academic institutionsbiotech firmspharmaceutical companiescontract research organizations (CROs) — partnerships mainly for collaborative R&D support.

Beyond the preview

Go deeper on Enzo Biochem, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enzo Biochem, Inc..